(BRC) Brady - Overview
Sector: Industrials | Industry: Security & Protection Services | Exchange: NYSE (USA) | Market Cap: 4.123m USD | Total Return: 24.2% in 12m
Avg Turnover: 22.3M
EPS Trend: 99.2%
Qual. Beats: 1
Rev. Trend: 95.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Pead
Brady Corporation (BRC) is a global manufacturer of identification solutions and workplace safety products, headquartered in Milwaukee, Wisconsin. The company operates through two primary segments: Identification Solutions and Workplace Safety, providing high-performance labels, signs, lockout/tagout devices, and tracking software to industries including aerospace, healthcare, and telecommunications.
The business model relies on a multi-channel distribution strategy, utilizing direct sales, digital platforms, and third-party distributors to reach a diverse industrial customer base. In the commercial printing and identification sector, competitive advantages are typically driven by proprietary material science and the ability to meet stringent regulatory compliance standards for safety and asset tracking.
For a detailed breakdown of the companys historical performance and valuation metrics, consider reviewing the latest data on ValueRay.
Founded in 1914, the company maintains a broad geographic footprint across the Americas, Asia-Pacific, and Europe. Its product portfolio focuses on high-durability applications where failure in identification or safety protocols can lead to significant operational risk or regulatory penalties.
- High-margin proprietary identification products drive consistent organic revenue and earnings growth
- Strategic acquisitions in industrial tracking and healthcare segments expand addressable market share
- Global industrial production levels and manufacturing capital expenditure dictate demand volumes
- Ongoing digital transformation and e-commerce channel expansion improve operational profit margins
- Fluctuations in raw material costs and global supply chain logistics impact margins
| Net Income: 209.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.55 > 1.0 |
| NWC/Revenue: 21.03% < 20% (prev 18.50%; Δ 2.53% < -1%) |
| CFO/TA 0.12 > 3% & CFO 223.2m > Net Income 209.7m |
| Net Debt (-25.3m) to EBITDA (306.6m): -0.08 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.8m) vs 12m ago -0.52% < -2% |
| Gross Margin: 51.11% > 18% (prev 0.51%; Δ 5.06k% > 0.5%) |
| Asset Turnover: 91.89% > 50% (prev 85.96%; Δ 5.93% > 0%) |
| Interest Coverage Ratio: 56.98 > 6 (EBITDA TTM 306.6m / Interest Expense TTM 4.61m) |
| A: 0.19 (Total Current Assets 678.9m - Total Current Liabilities 337.8m) / Total Assets 1.83b |
| B: 0.79 (Retained Earnings 1.44b / Total Assets 1.83b) |
| C: 0.15 (EBIT TTM 262.7m / Avg Total Assets 1.77b) |
| D: 2.82 (Book Value of Equity 1.37b / Total Liabilities 488.0m) |
| Altman-Z'' = 7.75 = AAA |
| DSRI: 1.07 (Receivables 266.4m/224.4m, Revenue 1.62b/1.46b) |
| GMI: 0.99 (GM 51.11% / 50.53%) |
| AQI: 0.94 (AQ_t 0.46 / AQ_t-1 0.49) |
| SGI: 1.11 (Revenue 1.62b / 1.46b) |
| TATA: -0.01 (NI 209.7m - CFO 223.2m) / TA 1.83b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of May 31, 2026, the stock is trading at USD 86.08 with a total of 179,201 shares traded.
Over the past week, the price has changed by +1.80%,
over one month by +5.01%,
over three months by -6.50% and
over the past year by +24.22%.
Brady has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy BRC.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 101.5 | 17.9% |
P/E Trailing = 19.8909
P/E Forward = 15.361
P/S = 2.5422
P/B = 3.068
P/EG = 1.6733
Revenue TTM = 1.62b USD
EBIT TTM = 262.7m USD
EBITDA TTM = 306.6m USD
Long Term Debt = 26.9m USD (from longTermDebt, last quarter)
Short Term Debt = 16.4m USD (from shortTermDebt, last quarter)
Debt = 150.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 61.7m
Net Debt = -25.3m USD (calculated: Debt 150.2m - CCE 175.5m)
Enterprise Value = 4.10b USD (4.12b + Debt 150.2m - CCE 175.5m)
Interest Coverage Ratio = 56.98 (Ebit TTM 262.7m / Interest Expense TTM 4.61m)
EV/FCF = 22.60x (Enterprise Value 4.10b / FCF TTM 181.3m)
FCF Yield = 4.42% (FCF TTM 181.3m / Enterprise Value 4.10b)
FCF Margin = 11.18% (FCF TTM 181.3m / Revenue TTM 1.62b)
Net Margin = 12.93% (Net Income TTM 209.7m / Revenue TTM 1.62b)
Gross Margin = 51.11% ((Revenue TTM 1.62b - Cost of Revenue TTM 793.0m) / Revenue TTM)
Gross Margin QoQ = 51.80% (prev 50.61%)
Tobins Q-Ratio = 2.24 (Enterprise Value 4.10b / Total Assets 1.83b)
Interest Expense / Debt = 3.07% (Interest Expense 4.61m / Debt 150.2m)
Taxrate = 21.22% (15.6m / 73.4m)
NOPAT = 206.9m (EBIT 262.7m * (1 - 21.22%))
Current Ratio = 2.01 (Total Current Assets 678.9m / Total Current Liabilities 337.8m)
Debt / Equity = 0.11 (Debt 150.2m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -0.08 (Net Debt -25.3m / EBITDA 306.6m)
Debt / FCF = -0.14 (Net Debt -25.3m / FCF TTM 181.3m)
Total Stockholder Equity = 1.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.88% (Net Income 209.7m / Total Assets 1.83b)
RoE = 16.46% (Net Income TTM 209.7m / Total Stockholder Equity 1.27b)
RoCE = 20.20% (EBIT 262.7m / Capital Employed (Equity 1.27b + L.T.Debt 26.9m))
RoIC = 14.84% (NOPAT 206.9m / Invested Capital 1.39b)
WACC = 7.76% (E(4.12b)/V(4.27b) * Re(7.95%) + D(150.2m)/V(4.27b) * Rd(3.07%) * (1-Tc(0.21)))
Discount Rate = 7.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -0.84%
[DCF] Terminal Value 75.73% ; FCFF base≈179.8m ; Y1≈183.8m ; Y5≈201.9m
[DCF] Fair Price = 72.38 (EV 3.13b - Net Debt -25.3m = Equity 3.15b / Shares 43.6m; r=8.35% [WACC [floored]]; 5y FCF grow 2.20% → 2.50% )
EPS Correlation: 99.17 | EPS CAGR: 11.53% | SUE: 4.0 | # QB: 1
Revenue Correlation: 95.92 | Revenue CAGR: 7.92% | SUE: 3.92 | # QB: 1
EPS next Quarter (2026-10-31): EPS=1.30 | Chg30d=-0.76% | Revisions=-33% | Analysts=2
EPS current Year (2026-07-31): EPS=5.28 | Chg30d=+4.66% | Revisions=-33% | GrowthEPS=+14.7% | GrowthRev=+9.2%
EPS next Year (2027-07-31): EPS=6.09 | Chg30d=+11.33% | Revisions=+0% | GrowthEPS=+15.4% | GrowthRev=+53.1%
[Analyst] Revisions Ratio: -33%